Enabling supply continuity by strengthening local manufacturing in Africa 30 October 2023 This report provides an overview of how MMV has been supporting African manufacturers to produce quality-assured antimalarial therapies.
Community Health Workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries 20 October 2023 Int J Infect Dis
MMV at a glance: introductory brochure 2023 4 October 2023 MMV at a glance is an introductory brochure sharing MMV's mission and highlighting our unique partnership model, the growth of our portfolio and the increasing impact of our access work.
Britain and beyond: achieving a stronger, safer world through malaria eradication 2 October 2023 A report from Zero Malaria Britain outlining how malaria threatens global health security and Britain's role in eradicating the disease.
Can malaria researchers slow the spread of drug resistance? 22 September 2023 Concerns that artemisinin combination treatments are losing their effectiveness against Plasmodium parasites have set scientists looking for alternatives.
Using Cryopreserved Plasmodium falciparum Sporozoites in a Humanized Mouse Model to Study Early Malaria Infection Processes and Test Prophylactic Treatments 31 August 2023
Development and application of a PBPK modeling strategy to support antimalarial drug development 15 August 2023 CPT Pharmacometrics Syst Pharmacol
Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase 26 July 2023 Res Sq
Moving seasonal malaria chemoprevention out of its geographical isolation 3 July 2023 Lancet Infect Dis
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial 12 June 2023 Lancet Infect Dis
Rectal artesunate for severe malaria, implementation research, Zambia 31 May 2023 Bull World Health Organ
Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum 26 May 2023 Nat Commun
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study 22 May 2023 Lancet Infect Dis
Integration and application of new approach methodologies in assessing the developmental hazards: Case study with an antimalarial drug 22 May 2023 Birth Defects Res
Advances in Malaria Pharmacology and the online Guide to MALARIA PHARMACOLOGY: IUPHAR Review X 20 May 2023
Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline 9 May 2023 American Society for Microbiology
Predicting Optimal Antimalarial Drug Combinations from a Standardized Plasmodium falciparum Humanized Mouse Model 3 May 2023 Antimicrobial Agents and Chemotherapy
Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana 24 April 2023 American Society for Microbiology
The impact of community delivery of intermittent preventive treatment of malaria in pregnancy on its coverage in four sub-Saharan African countries (Democratic Republic of the Congo, Madagascar, Mozambique, and Nigeria) 11 April 2023
Facilitators and barriers to seasonal malaria chemoprevention (SMC) uptake in Nigeria: a qualitative approach 10 April 2023 Malar J
Keeping the Promise: Product Development Partnerships’ Role in the New Age of Health Research and Product Development 6 April 2023 PDPs remain the chief developers of innovative medical technologies for people suffering with diseases and health threats underserved by traditional markets.
Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso 27 March 2023 Trop Med Infect Dis
